Trial Profile
A study to evaluate the co-relation between single nucleotide polymorphisms (SNPs) in SULT1E1 and treatment response to abiraterone acetate in patients with metastatic castration refractory prostate cancer (mCRPC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Mar 2016
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Biomarker; Pharmacodynamics
- 30 Mar 2016 New trial record